Project Grant HT94252410809
Award Date 10/1/24
Completion Date 9/30/27
Dollars Obligated $713K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- The Trustees of Indiana University will receive $713,250 through a three-year Project Grant award from the Defense Health Agency to support research targeting SOX11-FAK-mediated immune exhaustion in NF1-associated malignant peripheral nerve sheath tumor (MPNST). The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions...
- This federal Project Grant award of $158,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a genetically engineered mouse model of spinal ependymoma precursors in NF2-related schwannomatosis. The project will be conducted by the Trustees of Indiana University, a prominent public research university, over a performance period from September 15, 2025 to August 14, 2027. The award aims to advance biomedical research...
- The Trustees of Indiana University received a $525,000 Project Grant award from the Department of the Army Medical Command to support research targeting AXL in preclinical models of plexiform neurofibroma and malignant peripheral nerve sheath tumor chemoprevention. The three-year award, issued on July 1, 2021 under the Military Medical Research and Development program, will fund preclinical research investigating medical solutions for the battlefield by transforming health care for service...
- This Project Grant award, with a total funding of $158,500.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports an investigation into redox signaling as a potential therapeutic target for malignant peripheral nerve sheath tumors (MPNST). The ultimate period of performance for this grant is from July 1, 2024 to June 30, 2026. The grant recipient is the Trustees of Indiana University, doing business as Indiana...
- The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
- The Defense Health Agency awarded a $1,489,868 Project Grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 30, 2025 to September 29, 2029, will support the "OVARIAN CANCER ACADEMY: ADVANCING OVARIAN CANCER RESEARCH THROUGH MENTORSHIP, NETWORKING, AND COLLABORATIONS" initiative. The project aims to transform healthcare for military...
- This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
- The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
- The Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis), has been awarded a $1,576,423 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This federal grant, awarded on August 1, 2024, will support research to mitigate therapy resistance by combining CDK4/6 and PI3K/mTOR inhibition in pediatric and adolescent/young adult (AYA) osteosarcoma. The research project aims to develop...
- This $1,188,750 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Indiana University on "Ancestry-Dependent Stromal Cell Factors in Breast Cancer Progression." The 3-year project, running from January 31, 2025 to January 30, 2028, aims to investigate the role of stromal cell factors in breast cancer progression, with a focus on how ancestry influences these factors. As a comprehensive...